These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells. Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214 [TBL] [Abstract][Full Text] [Related]
27. The disaggregation of Hodgkin's lymph node: a preparative technique using a new dissociation chamber. Sitar G; Brusamolino E; Scivetti P; Borroni R Haematologica; 1987; 72(1):23-8. PubMed ID: 3108091 [No Abstract] [Full Text] [Related]
28. Malignant histiocytic lymphoma with large lacunar cells. Leahu S; Dobrea M Rom J Intern Med; 1997; 35(1-4):115-9. PubMed ID: 9562660 [TBL] [Abstract][Full Text] [Related]
29. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. Timens W; Visser L; Poppema S Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the Rye classification of Hodgkin's disease. The prognostic significance of cellular composition. Coppleson LW; Rappaport H; Strum SB; Rose J J Natl Cancer Inst; 1973 Aug; 51(2):379-90. PubMed ID: 4765366 [No Abstract] [Full Text] [Related]
31. [Transmission electron microscopy in the differential diagnosis of non-Hodgkin's lymphoma using fine-needle aspirates]. Lubiński J; Domagała W Patol Pol; 1988; 39(3):177-88. PubMed ID: 3247216 [No Abstract] [Full Text] [Related]
32. [Histopathology and histogenesis of Hodgkin's disease]. Belpomme D; Rappaport H; Mathé G Rev Prat; 1974 Oct; 24(45):3911-6, 3919-23. PubMed ID: 4548561 [No Abstract] [Full Text] [Related]
33. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review. Siebert JD; McClure SP; Banks PM; Gulley ML Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289 [TBL] [Abstract][Full Text] [Related]
34. International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Experimental cytology and histopathology. Thomas LB Natl Cancer Inst Monogr; 1973 May; 36():353-4. PubMed ID: 4582993 [No Abstract] [Full Text] [Related]
35. The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma. Achten R; Verhoef G; De Wolf-Peeters C Haematologica; 2003 Dec; 88(12):1431-2. PubMed ID: 14688002 [No Abstract] [Full Text] [Related]
36. [A study of the origin of tumor cells of Hodgkin's disease]. Cao M Zhonghua Bing Li Xue Za Zhi; 1986 Sep; 15(3):175-8. PubMed ID: 2953452 [No Abstract] [Full Text] [Related]
37. Hodgkin's cell lines: characteristics and possible pathogenetic implications. Diehl V; Burrichter H; Schaadt M; Kirchner HH; Fonatsch C; Stein H; Gerdes J; Heit W; Ziegler A Hematol Oncol; 1983; 1(2):139-47. PubMed ID: 6610620 [TBL] [Abstract][Full Text] [Related]
38. Proliferation characteristics of the various classes of cells in Hodgkin's disease. Peckham MJ; Cooper EH Cancer; 1969 Jul; 24(1):135-46. PubMed ID: 5790284 [No Abstract] [Full Text] [Related]
39. Further establishment of suspended-cell cultures from the human neoplastic lymph nodes and some morphological characteristics of each cell line. Oboshi S; Seido T; Shibata H; Sugano H Gan; 1969 Aug; 60(4):419-25. PubMed ID: 4186636 [No Abstract] [Full Text] [Related]
40. [Long-term investigation of immunoglobulin levels during treatment in patients with Hodgkin's disease (author's transl)]. Dienstbier Z; Koprivová H; Bechynĕ M; Foltýnová V; Zizkovský V; Mostecký H; Rezný Z; Jirkovský J Sb Lek; 1977 Mar; 79(3):89-96. PubMed ID: 850775 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]